New human data hints at psychedelics' potential to combat inflammation
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
We haven't written up this one. NPR has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
